Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing Facilities
Pharma
Sandoz sets ambitious goal to grow biosimilar bona fides by 2040
Spying a “golden decade” beyond Big Pharma's looming patent cliff, Sandoz is making big bets on its biosimilar capabilities in the coming years.
Fraiser Kansteiner
Sep 8, 2026 2:45pm
Fresenius Medical Care hit with FDA warning letter at Utah plant
Sep 3, 2026 3:31pm
FDA hands warning letters to manufacturers in China, India
Aug 19, 2026 10:20am
Celcuity needs facility sign-off to kick off its market launch
Aug 18, 2026 9:26am
BMS unveils $2.3B outlay for manufacturing campus in Houston
Aug 10, 2026 11:13am
BeOne joins reshoring parade with $300M US production expansion
Jul 23, 2026 11:18am
